GDANSK (Reuters) – Polish medical technology company MediSensonic plans to launch an initial public offering (IPO) on the Warsaw Stock Exchange in the fourth quarter, the company said in a press release on Thursday.
The company, known for creating innovative clinical-grade diagnostic and therapeutic devices, has so far raised over 50 million zlotys ($13.07 million)from grants and investors.
The latest capital increase, through the issuance of G series shares, brought the company’s valuation to over 70 million zlotys ($18.30 million).
($1 = 3.8258 zlotys)
(Reporting by Rafal Wojciech Nowak; Editing by Alexandra Hudson)
Comments